Clinically Validated Cardiovascular Products Now Available Online
Los Angeles, CA – April 4, 2017 – Los Angeles based biotechnology company Allied BioNutrition Corp, a leading-edge natural products innovator, announced 2 all-new clinically validated cardiovascular products available immediately online. The company is offering the following 2 products:
- CardioSustain, 100 mg Flavonoid Root Extract, 30 and 60 capsules
- ArterioSustain, 200 mg Flavonoid Root Extract, 30 capsules
“Finally, there are cardiovascular dietary supplements that have been clinically validated by world-class scientists that TRULY work,” says Paz Eilat, MD, CEO, CMO, of Allied BioNutrition.
“In fact, studies indicate that our biotechnology reduces cholesterol LDL oxidation by 55% and is up to 100 times more potent antioxidant than Vitamin E.” continued Eilat.”Our clinical trials and testimonials from people using our products indicate our biotechnology can sustain general cardiovascular health as well as promote blood flow in the arteries! This is especially important for people whose lifestyles may increase the level of cholesterol oxidation and free radicals in their bodies resulting from stress, being overweight, smoking, and even exercise. High levels of LDL oxidation may have significant impact on overall cardiovascular health.”
Allied BioNutrition’s focus is in the areas of cholesterol oxidation and cardiovascular health management. The company utilizes a clinically-based, field-proven, powerful blend of flavonoids from the polyphenol family. This compound is manufactured via a unique extraction process that was tested in an ISO certified lab which provides more than 10 times the flavonoids concentration than comparable flavonoids extracts on the marketing strategy. Moreover, our extract has shown unique and significant benefits in clinical trials for a wide range of cardiovascular health parameters.
CardioSustain contains Allied BioNutrition’s proprietary flavonoids root extract in a daily 100mg dose per capsule. CardioSustain may promote and maintain long-term cardiovascular health. Our biotechnology has been patented in the US and has been clinically validated by a world-class team of scientists. Furthermore, efficacy has been established from field evidence generated over several years.
CardioSustain uses our proprietary Flavonoids Root Extract as a natural and safe ingredient for managing heart health. This extract was created by world-class experts in cholesterol and heart health research, particularly in the areas of oxidative stress and antioxidants in cardiovascular health. A human study from Lipid Research Lab, Technion Faculty of Medicine, Rambam Medical Center, Haifa, Israel demonstrated that consumption of the proprietary Flavonoids Root Extract used in the Allied BioNutrition formula provided to participants for the study had the following key cardiovascular benefits:
- Reduced plasma susceptibility to oxidation by 19%
- Increased resistance of plasma LDL to cholesterol oxidation by 55% and to aggregation by 28%
- Reduced plasma triacylglycerol levels by 14%
- Retention (chondroitin sulfate binding ability) by 25%
- Reduced plasma LDL cholesterol by 9%
- Reduced systolic blood pressure by 10%
ArterioSustain contains our proprietary flavonoids root extract in a daily 200mg dose per capsule. In addition to all the above benefits offered by CardioSustain, ArterioSustain, with its double flavonoids concentration, promotes and maintains arterial health. This product has been patented in the US and has been clinically validated by a world-class team of scientists. Furthermore, efficacy has been established from field evidence generated over several years.
ArterioSustain uses our proprietary Flavonoids Root Extract as a natural and safe ingredient for managing arterial health. A double-blind placebo-controlled clinical trial was completed in October 2015 and published in the scientific journal Food and Nutrition Research in April 2016. After 1 year, the 94-person study yielded the following results: a statistically significant decrease in arterial wall thickness as measured by CIMT (carotid intima-media thickness) coupled with reduction in LDL cholesterol, triglycerides and blood pressure.
Allied BioNutrition is proud to introduce, for the first time ever, a natural health supplement that has shown clear evidence it may significantly attenuate the development of LDL oxidation and reduce CIMT – two critical factors for sustaining cardiovascular health.
Allied BioNutrition Corp. is based in Los Angeles, California, and is a formulator and manufacturer of superior nutritional supplements, specializing in cardiovascular health. The company was founded in 2015 and markets its products in the United States and throughout the world. Allied BioNutrition’s objective is to promote optimal health based on sound, scientific, legitimate research. For more information access call 888-711-6668 or e-mail us at info@AlliedBioNutrition.com.